Skip to main content

Table 5 Exogenous engineering methods for EVs

From: Recent advances in extracellular vesicle engineering and its applications to regenerative medicine

No.

EV source

Method

Loading material

Ref.

1

HepG2 Cell

Incubation

Bleomycin

[97]

2

MDA-MB-231 cell

Incubation

lactoferrin

[98]

3

Dendritic cell

Incubation

triptolide

[99]

4

ADMSC

Incubation

Ovalbumin

[100]

5

ADMSC

Incubation

Coenzyme Q10

[103]

6

HT92 Cell

Active incubation

Doxorubicin

[104]

7

neutrophil

Extrusion

Doxorubicin

[108]

8

bEnd.3 cell

Sonication

Doxorubicin

[110]

9

RAW 264.7

Sonication

Resveratrol

[113]

10

M2 macrophage

Sonication

Melatonin

[114]

11

M2 macrophage

Sonication

Berberine

[111]

12

J774A.1 cell

Sonication

Curcumin

[115]

13

RAW 264.7

Sonication

Baicalin

[116]

14

HEK293T

Sonication

Erastin/Rose Bengal

[112]

15

Plasma

Sonication

Quercetin

[117]

16

lens epithelial cell

Electroporation

Doxorubicin

[121]

17

Urine

Electroporation

Au NP

[118]

18

Urine

Electroporation

PMA/Fe-HSA@DOX

[119]

19

UCMSC

Electroporation

miR-29b mimic

[123]

20

BMSC

Electroporation

siRNA

[120]

21

BMSC

Electroporation

Rifampicin

[124]

22

BMSC

Freeze-thaw, Incubation, Active incubation, Sonication

bevacizumab

[107]

23

hEnSC

Freeze-thaw, Incubation, Active incubation, Sonication

Atorvastatin

[105]

24

Cabbage

Incubation, lipofectamin

Doxorubicin

[125]

25

UCMSC

Incubation, Freeze-thaw, Extrusion

Paclitaxel

[109]

26

Milk

Incubation, Sonication

Doxorubicin

[126]

27

Panc-1 cell

Incubation, Sonication

Gemcitabine

[127]

28

Milk

Incubation, Active incubation, Sonication

Doxorubicin

[106]